首页> 外文期刊>Chinese Jouranl of Integrative Medicine >Study on the Therapeutic Mechanism of the Active Principle of the Chinese Drug Paeoniae Radix 801 through Affinity Biosensors IAsys Plus Quartz Crystal Microbalance
【24h】

Study on the Therapeutic Mechanism of the Active Principle of the Chinese Drug Paeoniae Radix 801 through Affinity Biosensors IAsys Plus Quartz Crystal Microbalance

机译:亲和性生物传感器IAsys Plus石英晶体微天平对中药Rad药801有效成分的治疗机理研究

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: To study the targeted point and mechanism of the function of the blood-activating and stasis-removing Chinese drugs, Paeoniae Radix 801 (PR801) in its cardiovascular protective effects and its specific binding with endothelin 1(ET-1) as well as the dynamics of the two's interactive function by means of using affinity biosensors: IAsys Plus and quartz crystal microbalance (IAQCM). Methods: ET-1 was immobilized on the surfaces of IAQCM by using the new surface modification methods. The PR801 in the solution was detected by modified substrates and the specific binding between PR801 and ET-1 was studied. Results: The curves went up or down after adding PR801. There is specific binding between PR801 and ET-1. The bound mass were 0. 458 ng/mm~2 and 133.54 ng/cm~2, respectively. There exists relatively good stability with these two methods. Conclusion: The affinity biosensors: IAQCM can be used to study the interaction mechanism between PR801 and ET-1 , providing a new way to study the interaction mechanism of TCM. PR801 can bind ET-1 specifically in the experiments. Therefore, ET-1 is another target that PR801 can bind specifically besides thromboxane A_2.
机译:目的:研究活血化瘀中药Paeoniae Radix 801(PR801)的心血管保护作用及其与内皮素1(ET-1)的特异性结合以及与之结合的作用机制和目标。通过使用亲和性生物传感器(IAsys Plus和石英晶体微量天平(IAQCM))来实现二者交互功能的动力学。方法:采用新的表面改性方法将ET-1固定在IAQCM表面。用修饰的底物检测溶液中的PR801,并研究PR801与ET-1之间的特异性结合。结果:添加PR801后曲线上升或下降。 PR801和ET-1之间存在特定的绑定。结合质量分别为0. 458 ng / mm〜2和133.54 ng / cm〜2。这两种方法存在相对较好的稳定性。结论:亲和生物传感器:IAQCM可用于研究PR801与ET-1的相互作用机理,为研究中药的相互作用机理提供了新途径。 PR801可以在实验中特异性结合ET-1。因此,除了血栓烷A_2以外,ET-1是PR801可以特异性结合的另一个靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号